Anavex Life Sciences Stock Price Prediction

AVXL Stock  USD 9.11  0.09  1.00%   
As of now The RSI of Anavex Life's share price is above 80 . This suggests that the stock is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

82

 
Oversold
 
Overbought
The successful prediction of Anavex Life's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Anavex Life and does not consider all of the tangible or intangible factors available from Anavex Life's fundamental data. We analyze noise-free headlines and recent hype associated with Anavex Life Sciences, which may create opportunities for some arbitrage if properly timed.
Using Anavex Life hype-based prediction, you can estimate the value of Anavex Life Sciences from the perspective of Anavex Life response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Anavex Life to buy its stock at a price that has no basis in reality. In that case, they are not buying Anavex because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Anavex Life after-hype prediction price

    
  USD 8.74  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Anavex Life Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anavex Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
8.2018.5023.59
Details
Naive
Forecast
LowNextHigh
2.978.0613.15
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
9.009.089.16
Details

Anavex Life After-Hype Price Prediction Density Analysis

As far as predicting the price of Anavex Life at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Anavex Life or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Anavex Life, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Anavex Life Estimiated After-Hype Price Volatility

In the context of predicting Anavex Life's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Anavex Life's historical news coverage. Anavex Life's after-hype downside and upside margins for the prediction period are 3.65 and 13.83, respectively. We have considered Anavex Life's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
9.11
8.74
After-hype Price
13.83
Upside
Anavex Life is somewhat reliable at this time. Analysis and calculation of next after-hype price of Anavex Life Sciences is based on 3 months time horizon.

Anavex Life Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Anavex Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anavex Life backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Anavex Life, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.68 
5.09
 0.00  
  0.64 
0 Events / Month
1 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
9.11
8.74
4.06 
0.00  
Notes

Anavex Life Hype Timeline

Anavex Life Sciences is presently traded for 9.11. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.64. Anavex is anticipated to decline in value after the next headline, with the price expected to drop to 8.74. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -4.06%, whereas the daily expected return is presently at 0.68%. The volatility of related hype on Anavex Life is about 544.56%, with the expected price after the next announcement by competition of 9.75. About 32.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.51. Anavex Life Sciences had not issued any dividends in recent years. The entity had 1:4 split on the 7th of October 2015. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days.
Check out Anavex Life Basic Forecasting Models to cross-verify your projections.

Anavex Life Related Hype Analysis

Having access to credible news sources related to Anavex Life's direct competition is more important than ever and may enhance your ability to predict Anavex Life's future price movements. Getting to know how Anavex Life's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Anavex Life may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SAVACassava Sciences 0.00 0 per month 0.00 (0.03) 9.52 (8.62) 41.24 
INMBINmune Bio 0.00 0 per month 0.00 (0.14) 5.24 (7.10) 22.66 
BIVIBiovie Inc 0.00 0 per month 10.47  0.07  11.91 (9.39) 133.33 
CGTXCognition Therapeutics 0.00 0 per month 0.00 (0.11) 8.89 (10.34) 36.32 
ANVSAnnovis Bio 0.00 0 per month 0.00 (0.15) 6.62 (5.58) 20.79 
IOVAIovance Biotherapeutics 0.00 0 per month 0.00 (0.13) 7.18 (6.95) 23.06 
AXSMAxsome Therapeutics 0.00 0 per month 1.87  0.03  4.10 (3.78) 13.67 
NVAXNovavax 0.00 0 per month 0.00 (0.08) 9.47 (7.08) 38.60 
EXELExelixis 0.42 10 per month 0.85  0.17  3.14 (1.77) 14.75 
TGTXTG Therapeutics 0.00 0 per month 3.17  0.13  7.62 (4.62) 24.51 
VKTXViking Therapeutics 0.00 0 per month 0.00 (0.07) 6.24 (8.05) 34.61 
MDGLMadrigal Pharmaceuticals 15.47 6 per month 2.09  0.10  5.17 (3.96) 30.27 
BTAIBioXcel Therapeutics 0.00 0 per month 0.00 (0.07) 9.62 (9.09) 39.77 
RVPHWReviva Pharmaceuticals Holdings 0.00 0 per month 15.15  0.14  28.57 (22.22) 129.53 
EYENEyenovia 0.00 0 per month 0.00 (0.13) 11.76 (17.07) 92.81 
RNAZTranscode Therapeutics 0.00 0 per month 6.56  0.08  22.00 (11.43) 68.80 
KODKodiak Sciences 0.00 0 per month 2.77  0.25  9.70 (4.92) 18.79 

Anavex Life Additional Predictive Modules

Most predictive techniques to examine Anavex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Anavex using various technical indicators. When you analyze Anavex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Anavex Life Predictive Indicators

The successful prediction of Anavex Life stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Anavex Life Sciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Anavex Life based on analysis of Anavex Life hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Anavex Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Anavex Life's related companies.

Story Coverage note for Anavex Life

The number of cover stories for Anavex Life depends on current market conditions and Anavex Life's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Anavex Life is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Anavex Life's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Anavex Life Short Properties

Anavex Life's future price predictability will typically decrease when Anavex Life's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Anavex Life Sciences often depends not only on the future outlook of the potential Anavex Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anavex Life's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding79.8 M
Cash And Short Term Investments151 M
When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports:
Check out Anavex Life Basic Forecasting Models to cross-verify your projections.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.